Insider · CIK 0001225199

GODDARD COLIN

Reports to the SEC for 4 companies · MELVILLE, NY

sec.gov

Transactions

Companies

Filings

CIK

0001225199

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-12-05	OSTXOS Therapies Inc · Non-qualified stock options (right to buy)A Award	Director	AAward	+400K sh	—	—	400,000
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Director	DDisposition to Issuer	−7,800 sh	$24.00	−$187K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	$17.98	−$243K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−28K sh	$13.63	−$382K	0
2018-12-21	ENDOCYTE INCD Disposition to Issuer	Director	DDisposition to Issuer	−3,300 sh	$24.00	−$79.2K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.5K sh	$13.19	−$257K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−13.5K sh	$20.65	−$279K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14K sh	$17.31	−$242K	0
2018-12-21	ENDOCYTE INCStock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−19.5K sh	$21.73	−$424K	0
2018-05-03	ENDOCYTE INCStock Option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2018-05-03	ENDOCYTE INCA Award	Director	AAward	+3,300 sh	—	—	11,100
2017-05-04	ENDOCYTE INCA Award	Director	AAward	+3,300 sh	—	—	7,800
2017-05-04	ENDOCYTE INCStock Option (right to buy)A Award	Director	AAward	+19.5K sh	—	—	19,500
2016-05-05	ENDOCYTE INCStock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2016-05-05	ENDOCYTE INCA Award	Director	AAward	+2,250 sh	—	—	4,500
2015-05-14	ENDOCYTE INCStock Option (right to buy)A Award	Director	AAward	+13.5K sh	—	—	13,500
2015-05-14	ENDOCYTE INCA Award	Director	AAward	+2,250 sh	—	—	2,250
2013-11-07	ENDOCYTE INCStock Option (right to buy)A Award	Director	AAward	+28K sh	—	—	28,000
2012-07-30	HUMAN GENOME SCIENCES INCU Disposition from Tender	Director	UDisposition from Tender	−6,560 sh	$14.25	−$93.5K	0
2012-07-30	HUMAN GENOME SCIENCES INCD Disposition to Issuer	Director	DDisposition to Issuer	−4,166 sh	$14.25	−$59.4K	6,560
2012-07-30	HUMAN GENOME SCIENCES INCNon-Employee Director Stock Option - Right to BuyD Disposition to Issuer	Director	DDisposition to Issuer	−16K sh	$14.25	−$228K	0
2012-05-17	HUMAN GENOME SCIENCES INCA Award	Director	AAward	+2,500 sh	—	—	10,726
2012-05-17	HUMAN GENOME SCIENCES INCNon-Employee Director Stock Option - Right to BuyA Award	Director	AAward	+16K sh	—	—	16,000
2011-08-04	HUMAN GENOME SCIENCES INCP Purchase	Director	PPurchase	+3,000 sh	$16.17	+$48.5K	8,226
2011-05-12	HUMAN GENOME SCIENCES INCNon-Employee Director Stock Option - Right to BuyA Award	Director	AAward	+16K sh	—	—	16,000
2011-05-12	HUMAN GENOME SCIENCES INCA Award	Director	AAward	+2,500 sh	—	—	5,226
2011-03-22	HUMAN GENOME SCIENCES INCP Purchase	Director	PPurchase	+2,726 sh	$27.41	+$74.7K	2,726
2010-12-13	HUMAN GENOME SCIENCES INCNon-Employee Director Stock Option - Right to BuyA Award	Director	AAward	+25K sh	—	—	25,000
2010-06-07	OSI PHARMACEUTICALS INCU Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−4,175 sh	$57.50	−$240K	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	$57.50	−$2.88M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−37.5K sh	$57.50	−$2.16M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−47K sh	$57.50	−$2.7M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−62.5K sh	$57.50	−$3.59M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−51.4K sh	$57.50	−$2.96M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−60.7K sh	$57.50	−$3.49M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−50K sh	$57.50	−$2.88M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−135K sh	$57.50	−$7.76M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−34K sh	$57.50	−$1.96M	0
2010-06-03	OSI PHARMACEUTICALS INCD Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−67.4K sh	$57.50	−$3.87M	4,175
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−45K sh	$57.50	−$2.59M	0
2010-06-03	OSI PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director, Chief Executive Officer	DDisposition to Issuer	−135K sh	$57.50	−$7.76M	0
2010-06-03	OSI PHARMACEUTICALS INCU Disposition from Tender	Director, Chief Executive Officer	UDisposition from Tender	−86.7K sh	$57.50	−$4.99M	71,557
2010-03-01	OSI PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+66K sh	$23.25	+$1.53M	224,265
2010-03-01	OSI PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−66K sh	$55.17	−$3.64M	158,265
2010-03-01	OSI PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−66K sh	—	—	34,000
2009-12-16	OSI PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,968 sh	$32.89	−$97.6K	158,265
2009-12-15	OSI PHARMACEUTICALS INCA Award	Director, Chief Executive Officer	AAward	+35K sh	—	—	161,233
2009-12-15	OSI PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+135K sh	—	—	135,000
2009-12-13	OSI PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,487 sh	$34.75	−$51.7K	126,233
2009-12-12	OSI PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−2,493 sh	$34.75	−$86.6K	127,720

Recent filings

Accepted (ET)
Feb 145
GODDARD COLIN0000921895-25-000493
SEC(opens sec.gov)
Dec 214
GODDARD COLIN0001104659-18-074344
SEC(opens sec.gov)
May 44
GODDARD COLIN0001179110-18-006321
SEC(opens sec.gov)
May 54
ENDOCYTE INC0001179110-17-006710
SEC(opens sec.gov)
May 64
ENDOCYTE INC0001179110-16-024069
SEC(opens sec.gov)
May 184
ENDOCYTE INC0001144204-15-032018
SEC(opens sec.gov)
Nov 84
ENDOCYTE INC0001144204-13-060023
SEC(opens sec.gov)
Aug 14
GODDARD COLIN0001225208-12-016972
SEC(opens sec.gov)

Companies

Address

C/O OSI PHARMACEUTICALS, INC. 41 PINELAWN ROAD

MELVILLE, NY, 11747